Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Status: Enrolling
Updated:  9/25/2015
Clinical Research Facility
mi
from
Tampa, FL
AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Status: Enrolling
Updated: 9/25/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Status: Enrolling
Updated:  9/25/2015
Clinical Research Facility
mi
from
St. Louis Park, MN
AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Status: Enrolling
Updated: 9/25/2015
Clinical Research Facility
mi
from
St. Louis Park, MN
Click here to add this to my saved trials
AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Status: Enrolling
Updated:  9/25/2015
Clinical Research Facility
mi
from
Winston Salem, NC
AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Status: Enrolling
Updated: 9/25/2015
Clinical Research Facility
mi
from
Winston Salem, NC
Click here to add this to my saved trials
AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Status: Enrolling
Updated:  9/25/2015
Clinical Research Facility
mi
from
Columbus, OH
AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Status: Enrolling
Updated: 9/25/2015
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Status: Enrolling
Updated:  9/25/2015
Clinical Research Facility
mi
from
Philadelphia, PA
AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Status: Enrolling
Updated: 9/25/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Status: Enrolling
Updated:  9/25/2015
Research Site
mi
from
Adelaide,
AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Status: Enrolling
Updated: 9/25/2015
Research Site
mi
from
Adelaide,
Click here to add this to my saved trials
Tadalafil in Treating Patients Undergoing Surgery for Cancer of the Oral Cavity or Oropharynx
Pilot Study of Phosphodiesterase-5 Inhibitor Tadalafil (Cialis) as an Immunomodulator in Patients With Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
Status: Enrolling
Updated:  9/25/2015
University of Miami Sylvester Comprehensive Cancer Center - Miami
mi
from
Miami, FL
Tadalafil in Treating Patients Undergoing Surgery for Cancer of the Oral Cavity or Oropharynx
Pilot Study of Phosphodiesterase-5 Inhibitor Tadalafil (Cialis) as an Immunomodulator in Patients With Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
Status: Enrolling
Updated: 9/25/2015
University of Miami Sylvester Comprehensive Cancer Center - Miami
mi
from
Miami, FL
Click here to add this to my saved trials
4D-CT-based Ventilation Imaging for Adaptive Functional Guidance in Radiotherapy
4D-CT-based Ventilation Imaging for Adaptive Functional Guidance in Radiotherapy
Status: Enrolling
Updated:  9/25/2015
Stanford University School of Medicine
mi
from
Stanford, CA
4D-CT-based Ventilation Imaging for Adaptive Functional Guidance in Radiotherapy
4D-CT-based Ventilation Imaging for Adaptive Functional Guidance in Radiotherapy
Status: Enrolling
Updated: 9/25/2015
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Collection of Blood, Bone Marrow, Tumor or Tissue Samples
Acquisition of Blood, Bone Marrow, Tumor, or Tissue Samples
Status: Enrolling
Updated:  9/26/2015
National Naval Medical Center
mi
from
Bethesda, MD
Collection of Blood, Bone Marrow, Tumor or Tissue Samples
Acquisition of Blood, Bone Marrow, Tumor, or Tissue Samples
Status: Enrolling
Updated: 9/26/2015
National Naval Medical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Collection of Blood, Bone Marrow, Tumor or Tissue Samples
Acquisition of Blood, Bone Marrow, Tumor, or Tissue Samples
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Collection of Blood, Bone Marrow, Tumor or Tissue Samples
Acquisition of Blood, Bone Marrow, Tumor, or Tissue Samples
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Collection of Alveolar Soft Part Sarcoma and Blood Specimens for Research
Procurement of Blood and Tissue From Patients With Primary and Metastatic Alveolar Soft Part Sarcoma and Blood From Healthy Controls for In Vitro and In Vivo Model Development
Status: Enrolling
Updated:  9/26/2015
National Cancer Institute , 9000 Rockville Pike
mi
from
Bethesda, MD
Collection of Alveolar Soft Part Sarcoma and Blood Specimens for Research
Procurement of Blood and Tissue From Patients With Primary and Metastatic Alveolar Soft Part Sarcoma and Blood From Healthy Controls for In Vitro and In Vivo Model Development
Status: Enrolling
Updated: 9/26/2015
National Cancer Institute , 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease
Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease
Status: Enrolling
Updated:  9/26/2015
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike
mi
from
Bethesda, MD
Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease
Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease
Status: Enrolling
Updated: 9/26/2015
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Gene Therapy for the Treatment of Brain Tumors
Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction With the Thymidine Kinase Gene and Intravenous Ganciclovir
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Gene Therapy for the Treatment of Brain Tumors
Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction With the Thymidine Kinase Gene and Intravenous Ganciclovir
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype
Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype
Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer
A Randomized Phase II Study of a PSA-Based Vaccine in Patients With Localized Prostate Cancer Receiving Standard Radiotherapy
Status: Enrolling
Updated:  9/26/2015
National Cancer Institute , 9000 Rockville Pike
mi
from
Bethesda, MD
PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer
A Randomized Phase II Study of a PSA-Based Vaccine in Patients With Localized Prostate Cancer Receiving Standard Radiotherapy
Status: Enrolling
Updated: 9/26/2015
National Cancer Institute , 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Late Effects of Treatment for Sarcomas in Children
Late Effects of Treatment in Survivors of Pediatric Sarcomas
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Late Effects of Treatment for Sarcomas in Children
Late Effects of Treatment in Survivors of Pediatric Sarcomas
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer
A Pilot Study to Evaluate Angiogenesis After Treatment With Bevacizumab (Anti-VEGF Humanized Monoclonal Antibody) in Previously Untreated Patients With Inflammatory Breast Cancer or Locally Advanced Breast Cancer
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer
A Pilot Study to Evaluate Angiogenesis After Treatment With Bevacizumab (Anti-VEGF Humanized Monoclonal Antibody) in Previously Untreated Patients With Inflammatory Breast Cancer or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein
Phase I Study of HeFi-1 in Refractory CD30-Positive Malignancy
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein
Phase I Study of HeFi-1 in Refractory CD30-Positive Malignancy
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein
Phase I Study of HeFi-1 in Refractory CD30-Positive Malignancy
Status: Enrolling
Updated:  9/26/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein
Phase I Study of HeFi-1 in Refractory CD30-Positive Malignancy
Status: Enrolling
Updated: 9/26/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors
A Pilot Trial of a CEA-TRICOM Based Vaccine and Radiation to Liver Metastasis in Adults With CEA Positive Solid Tumors
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors
A Pilot Trial of a CEA-TRICOM Based Vaccine and Radiation to Liver Metastasis in Adults With CEA Positive Solid Tumors
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Views of Cancer Patients Regarding Financial Conflicts of Interest
Ethics Study to Understand the Views of Cancer Patients Regarding Financial Conflicts of Interest in Research
Status: Enrolling
Updated:  9/26/2015
University of Colorado Cancer Center
mi
from
Denver, CO
Views of Cancer Patients Regarding Financial Conflicts of Interest
Ethics Study to Understand the Views of Cancer Patients Regarding Financial Conflicts of Interest in Research
Status: Enrolling
Updated: 9/26/2015
University of Colorado Cancer Center
mi
from
Denver, CO
Click here to add this to my saved trials
Views of Cancer Patients Regarding Financial Conflicts of Interest
Ethics Study to Understand the Views of Cancer Patients Regarding Financial Conflicts of Interest in Research
Status: Enrolling
Updated:  9/26/2015
Yale University
mi
from
New Haven, CT
Views of Cancer Patients Regarding Financial Conflicts of Interest
Ethics Study to Understand the Views of Cancer Patients Regarding Financial Conflicts of Interest in Research
Status: Enrolling
Updated: 9/26/2015
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Views of Cancer Patients Regarding Financial Conflicts of Interest
Ethics Study to Understand the Views of Cancer Patients Regarding Financial Conflicts of Interest in Research
Status: Enrolling
Updated:  9/26/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Views of Cancer Patients Regarding Financial Conflicts of Interest
Ethics Study to Understand the Views of Cancer Patients Regarding Financial Conflicts of Interest in Research
Status: Enrolling
Updated: 9/26/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Views of Cancer Patients Regarding Financial Conflicts of Interest
Ethics Study to Understand the Views of Cancer Patients Regarding Financial Conflicts of Interest in Research
Status: Enrolling
Updated:  9/26/2015
Columbia University
mi
from
New York, NY
Views of Cancer Patients Regarding Financial Conflicts of Interest
Ethics Study to Understand the Views of Cancer Patients Regarding Financial Conflicts of Interest in Research
Status: Enrolling
Updated: 9/26/2015
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Views of Cancer Patients Regarding Financial Conflicts of Interest
Ethics Study to Understand the Views of Cancer Patients Regarding Financial Conflicts of Interest in Research
Status: Enrolling
Updated:  9/26/2015
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Views of Cancer Patients Regarding Financial Conflicts of Interest
Ethics Study to Understand the Views of Cancer Patients Regarding Financial Conflicts of Interest in Research
Status: Enrolling
Updated: 9/26/2015
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Salivary Proteins in Disease and Health
Salivary Proteomics in Disease and Health
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Salivary Proteins in Disease and Health
Salivary Proteomics in Disease and Health
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
Systemic Immunosupressive Therapy for Eye Diseases (SITE) Cohort Study
Status: Enrolling
Updated:  9/26/2015
Johns Hopkins University
mi
from
Baltimore, MD
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
Systemic Immunosupressive Therapy for Eye Diseases (SITE) Cohort Study
Status: Enrolling
Updated: 9/26/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
Systemic Immunosupressive Therapy for Eye Diseases (SITE) Cohort Study
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
Systemic Immunosupressive Therapy for Eye Diseases (SITE) Cohort Study
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
Systemic Immunosupressive Therapy for Eye Diseases (SITE) Cohort Study
Status: Enrolling
Updated:  9/26/2015
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
Systemic Immunosupressive Therapy for Eye Diseases (SITE) Cohort Study
Status: Enrolling
Updated: 9/26/2015
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
Click here to add this to my saved trials
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
Systemic Immunosupressive Therapy for Eye Diseases (SITE) Cohort Study
Status: Enrolling
Updated:  9/26/2015
Oregon Health and Sciences University
mi
from
Portland, OR
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
Systemic Immunosupressive Therapy for Eye Diseases (SITE) Cohort Study
Status: Enrolling
Updated: 9/26/2015
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1a
A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1 Alpha
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1a
A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1 Alpha
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
CDDO to Treat Solid Tumors and Lymphomas
Phase I Study of CDDO in Solid Tumors and Lymphomas
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
CDDO to Treat Solid Tumors and Lymphomas
Phase I Study of CDDO in Solid Tumors and Lymphomas
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer
Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer
Status: Enrolling
Updated:  9/26/2015
National Cancer Institute , 9000 Rockville Pike
mi
from
Bethesda, MD
Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer
Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer
Status: Enrolling
Updated: 9/26/2015
National Cancer Institute , 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Family Health Study (Validation of a Family History of Cancer Questionnaire for Risk Factor Surveillance)
Family Health Study (Validation of a Family History of Cancer Questionnaire for Risk Factor Surveillance)
Status: Enrolling
Updated:  9/26/2015
National Cancer Institute , 9000 Rockville Pike
mi
from
Bethesda, MD
Family Health Study (Validation of a Family History of Cancer Questionnaire for Risk Factor Surveillance)
Family Health Study (Validation of a Family History of Cancer Questionnaire for Risk Factor Surveillance)
Status: Enrolling
Updated: 9/26/2015
National Cancer Institute , 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders
Status: Enrolling
Updated:  9/26/2015
VA Medical Center, Washington D.C.
mi
from
Washington,
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders
Status: Enrolling
Updated: 9/26/2015
VA Medical Center, Washington D.C.
mi
from
Washington,
Click here to add this to my saved trials
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
African American Families and Lung Cancer Study
African American Families and Lung Cancer Study
Status: Enrolling
Updated:  9/26/2015
MedStar Washington Hospital Center
mi
from
Washington,
African American Families and Lung Cancer Study
African American Families and Lung Cancer Study
Status: Enrolling
Updated: 9/26/2015
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, MD: A Pilot Study of Biomarkers
Status: Enrolling
Updated:  9/26/2015
Johns Hopkins University
mi
from
Baltimore, MD
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, MD: A Pilot Study of Biomarkers
Status: Enrolling
Updated: 9/26/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas
A Phase I Study of ABT-888 in Combination With Topotecan Hydrochloride in Adults With Refractory Solid Tumors and Lymphomas
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas
A Phase I Study of ABT-888 in Combination With Topotecan Hydrochloride in Adults With Refractory Solid Tumors and Lymphomas
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
SNX-5422 to Treat Solid Tumor Cancers and Lymphomas
Phase I Study of SNX-5422 Mesylate in Adults With Refractory Solid Tumor Malignancies and Lymphomas
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
SNX-5422 to Treat Solid Tumor Cancers and Lymphomas
Phase I Study of SNX-5422 Mesylate in Adults With Refractory Solid Tumor Malignancies and Lymphomas
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer
Pilot Trial to Identify and Characterize Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer
Pilot Trial to Identify and Characterize Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Informed Consent in Pediatric Cancer Trials
Informed Consent in Pediatric Phase I Cancer Trials
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Informed Consent in Pediatric Cancer Trials
Informed Consent in Pediatric Phase I Cancer Trials
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Informed Consent in Pediatric Cancer Trials
Informed Consent in Pediatric Phase I Cancer Trials
Status: Enrolling
Updated:  9/26/2015
Cleveland Clinic Foundation Childrens Hospital
mi
from
Cleveland, OH
Informed Consent in Pediatric Cancer Trials
Informed Consent in Pediatric Phase I Cancer Trials
Status: Enrolling
Updated: 9/26/2015
Cleveland Clinic Foundation Childrens Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
A Phase 1 Pharmacokinetic And Pharmacodynamic Study Of Pf-03446962 In Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  9/27/2015
Fox Chase Cancer Center
mi
from
Philadelphia, PA
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
A Phase 1 Pharmacokinetic And Pharmacodynamic Study Of Pf-03446962 In Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 9/27/2015
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
A Phase 1 Pharmacokinetic And Pharmacodynamic Study Of Pf-03446962 In Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  9/27/2015
Medical University of South Carolina Hollings Cancer Center
mi
from
Charleston, SC
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
A Phase 1 Pharmacokinetic And Pharmacodynamic Study Of Pf-03446962 In Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 9/27/2015
Medical University of South Carolina Hollings Cancer Center
mi
from
Charleston, SC
Click here to add this to my saved trials
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
A Phase 1 Pharmacokinetic And Pharmacodynamic Study Of Pf-03446962 In Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  9/27/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
A Phase 1 Pharmacokinetic And Pharmacodynamic Study Of Pf-03446962 In Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 9/27/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
A Phase 1 Pharmacokinetic And Pharmacodynamic Study Of Pf-03446962 In Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  9/27/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
A Phase 1 Pharmacokinetic And Pharmacodynamic Study Of Pf-03446962 In Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 9/27/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
A Phase 1 Pharmacokinetic And Pharmacodynamic Study Of Pf-03446962 In Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  9/27/2015
S.C Diagnostica Radiologica 2
mi
from
Milano,
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
A Phase 1 Pharmacokinetic And Pharmacodynamic Study Of Pf-03446962 In Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 9/27/2015
S.C Diagnostica Radiologica 2
mi
from
Milano,
Click here to add this to my saved trials
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
A Phase I Clinical and Biological Evaluation of Combined EGFR Blockade With Erlotinib and Cetuximab in Patients With Advanced Cancer
Status: Enrolling
Updated:  9/28/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
A Phase I Clinical and Biological Evaluation of Combined EGFR Blockade With Erlotinib and Cetuximab in Patients With Advanced Cancer
Status: Enrolling
Updated: 9/28/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials